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The availability of an integrated model including the whole patient population provides insight into the role of age-related changes in the disposition of lamotrigine, and potential implications for dose optimisation.
should read The availability of an integrated model including the whole patient population provides insight into the role of age-related changes in the disposition of lamotrigine, and potential implications for maintenance dose optimisation in any future trials. Table 4 , heading which previously read Optimised dosing regimens and predicted Css per age group should read Optimised maintenance dosing regimens and predicted steady-state concentration (Css) per age group in the simulated scenarios Table 4 , footnote which previously read Each column summarises the proportion of patients in each group who are exposed above the toxicity level (20 mg/L), above the therapeutic maximum (15 mg/L), and below the therapeutic minimum (2.5 mg/L) C ss steady-state concentrations should read Each column summarises the proportion of patients in each group who are exposed above the toxicity level (20 The original article can be found online at https://doi.org/10.1007/ s40262-017-0614-5.
& Oscar Della Pasqua oscar.e.della-pasqua@gsk.com mg/L), above the therapeutic maximum (15 mg/L), and below the therapeutic minimum (2.5 mg/L) These scenarios do not include the initiation dose or titration steps, which are required to reduce the risk of serious cutaneous adverse reactions and account for interindividual differences in pharmacodynamics and safety Section 4, para 8, lines 4-5 which previously read …simulated regimens show that lamotrigine doses may be titrated at the onset of therapy… should read …simulated regimens show that lamotrigine doses should be titrated at the onset of therapy… Section 4, para 8, lines 7-10 which previously read In fact, understanding of the role of covariate factors can aid the clinician achieving a preset target concentration to a moderate degree.
should read In fact, understanding of the role of covariate factors can aid investigators in achieving a pre-set target steady state concentration to a moderate degree, in proposed clinical trials.
Section 4, para 8, lines 13-15 which previously read It can be anticipated that such a dosing algorithm may serve as a tool for clinicians at the start of treatment. Once a target maintenance dose is reached, model-guided dose adjustments can be made in conjunction with TDM sampling to further personalise therapy should read It can be anticipated that such a dosing algorithm may serve as a tool for investigators when developing their trial protocols. Once a target maintenance dose is reached, modelguided dose adjustments may be considered in conjunction with TDM sampling to further personalise therapy.
Section 5, para 1, lines 23-25 which previously read These results should form the basis for the dose rationale in prospective clinical trials in infants and toddlers.
should read These results should form the basis for the dose rationale in any future clinical trials in infants and toddlers. As the recommended low initiation dose, titration steps and interindividual differences in pharmacodynamics and safety were not considered here, they do not constitute recommendations for patients in clinical practice.
